Pharmacokinetics of linezolid in the mediastinum and pleural space

International Journal of Infectious Diseases

Volumn 17, Issue 11, 2013, Pages e1060-e1061

  Tsuji, Yasuhiro ^a   Hashimoto, Wataru ^b   Taniguchi, Shinichiro ^c   Hiraki, Yoichi ^d   Mizoguchi, Akiko ^c   Yukawa, Eiji ^e   To, Hideto ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c SASEBO CHUO HOSPITAL   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION KUMAMOTO MEDICAL CENTER   (Japan)

^e DAIICHI UNIVERSITY OF PHARMACY   (Japan)

Author keywords

Cardiovascular surgery; Linezolid; Mediastinitis; Penetration to mediastinum; Pharmacokinetics

Indexed keywords

LINEZOLID;

AREA UNDER THE CURVE; ARTICLE; CASE REPORT; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; HUMAN; HUMAN TISSUE; MALE; MEDIASTINITIS; MEDIASTINUM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; PHARMACOKINETICS; PLASMA CONCENTRATION-TIME CURVE; PLEURA CAVITY; PLEURA EFFUSION; PLEURA FLUID;

CARDIOVASCULAR SURGERY; LINEZOLID; MEDIASTINITIS; PENETRATION TO MEDIASTINUM; PHARMACOKINETICS;

ACETAMIDES; ANTI-INFECTIVE AGENTS; EXTRACELLULAR FLUID; HUMANS; MALE; MEDIASTINITIS; MEDIASTINUM; OXAZOLIDINONES; PERMEABILITY; PLEURAL CAVITY; PLEURAL EFFUSION;

EID: 84885340021     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2013.03.008     Document Type: Article

References (5)

1. Mekontso-Dessap A., Kirsch M., Brun-Buisson C., Loisance D. Poststernotomy mediastinitis due to Staphylococcus aureus: comparison of methicillin-resistant and methicillin-susceptible cases. Clin Infect Dis 2001, 32:877-883.
2. Sacar S., Sacar M., Aybek H., Turgut H., Onem G., Cevahir N., et al. Comparison of the therapeutic efficacy of linezolid and vancomycin and correlation of serum and tissue malondialdehyde and myeloperoxidase in an experimental mediastinitis model. J Surg Res 2009, 152:89-95.
3. Gee T., Ellis R., Marshall G., Andrews J., Ashby J., Wise R. Pharmacokinetics and tissue penetration of linezolid following multiple oral doses. Antimicrob Agents Chemother 2001, 45:1843-1846.
4. Dowzicky M.J. Susceptibility to tigecycline and linezolid among Gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009. Clin Ther 2011, 33:1964-1973.
5. Andes D., van Ogtrop M.L., Peng J., Craig W.A. In vivo pharmacodynamics of a new oxazolidinone (linezolid). Antimicrob Agents Chemother 2002, 46:3484-3489.